Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Linnane Pharma AB
AB
Active
Org 5569494346
Möllarevägen 10, 245 61
Staffanstorp
Activities of holding companies
·
NACE 6421
Est. 2013 · 12 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Activities of holding companies
/
Linnane Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
8M
6M
4M
2M
0M
2M
2021
4M
+100%
2022
4M
0%
2023
5M
+25%
2024
6M
+20%
2025
EBITDA
SEK millions
4M
3M
2M
1M
0M
0M
2021
2M
+200%
2022
2M
0%
2023
3M
+50%
2024
3M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
2 123
3 900
4 300
5 358
5 658
Staff expenses
—
—
—
—
—
EBITDA
−5
2 046
1 753
2 633
2 706
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−5
2 046
1 753
2 633
2 706
Net financials
−97
−1 044
8 852
9 627
−591
Profit before tax
43
753
10 454
11 810
1 584
Tax
−2
−157
−100
−283
−331
Net profit
41
596
10 354
11 527
1 253
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
46 992
70 920
77 192
81 387
82 005
Equity
41 024
41 620
51 974
63 502
64 755
Long-term debt
3 200
26 027
20 170
13 638
12 425
Short-term debt
2 767
3 023
4 647
3 397
3 445
Total debt
5 967
29 050
24 817
17 035
15 870
Financial ratios
5-year trend
EBITDA margin
47.8%
This company
15.8%
Market median
203% above market
2021
2025
Equity ratio
79.0%
This company
38.2%
Market median
107% above market
2021
2025
Return on equity
1.9%
This company
18.4%
Market median
90% below market
2021
2025
Net profit margin
22.1%
This company
8.1%
Market median
173% above market
2021
2025
Asset turnover
0.07×
This company
1.12×
Market median
94% below market
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
56% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Linnane Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
